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Neuritin is a new neurotropic factor implicated in nervous system development and
plasticity. Studies have shown that Neuritin is upregulated in injured nerves, suggesting
that it is involved in nerve repair. To test this hypothesis, we investigated whether
recombinant human Neuritin could restore nerve structure and function in a rat model
of sciatic nerve injury. Neuritin treatment had a dose-dependent effect on functional
recovery 4 weeks after injury, as determined by the walking-track test. Similar trends
were observed for gastrocnemius muscular strength and nerve conduction velocity.
Additionally, sciatic nerve fiber density and organization as well as degree of remyelination
were increased, while growth-associated protein 43 and neurofilament 200 expression
was upregulated upon treatment with Neuritin. These findings demonstrate that Neuritin
stimulates nerve regeneration and functional recovery and thus promotes the repair of
injured sciatic nerves.
Keywords: neuritin, sciatic nerve injury, restoration, walking-track test, growth-associated protein 43,
neurofilament 200
INTRODUCTION
Neurotrophic factors supported the migration, growth, and survival of neurons. These secreted
factors are also critical for the maintenance and plasticity of the adult nervous system and are of
clinical interest since they can serve as therapeutic agents in the treatment of neurodegenerative
disorders and nerve injury (Vilar and Mira, 2016). Neuritin is a neurotropic factor that has
been implicated in nervous system development and plasticity (Nedivi et al., 1993). It is highly
expressed in the developing nervous system, with the level decreasing upon maturation (Naeve
et al., 1997). However, Neuritin is upregulated in adult neural structures, such as the olfactory bulb,
hippocampus, visual cortex, and Purkinje fibers (Nedivi et al., 1996, 2001; Yamagata et al., 1998) as
well as during transient global ischemia, traumatic brain injury, spinal cord injury, and androgen
treatment (Di Giovanni et al., 2005b; Han et al., 2007; Fargo et al., 2008; He et al., 2013). The latter
was shown to promote functional recovery of injured facial nerves, which was associated with
Neuritin upregulation; conversely, blocking androgen reduced Neuritin expression, suggesting a
correlation between Neuritin, and functional recovery of injured facial nerves (Fargo et al., 2008).
Neuritin is a secreted monomeric protein that promotes neurite outgrowth and the stabilization
and maturation of synapses in cultured neurons (Nedivi et al., 1998; Cantallops et al., 2000;
Javaherian and Cline, 2005). Neuritin overexpression induces the recovery of crushed optic
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nerve in mouse (Sharma et al., 2015). We recently showed
that recombinant Neuritin protects neurons against apoptosis
following spinal cord injury (Gao et al., 2016). In the present
study, we investigated whether Neuritin can restore nerve
structure and function in a rat model of sciatic nerve injury.
The results reveal that recombinant hNeuritin accelerates the
functional recovery and regeneration of injured sciatic nerves,
highlighting its potential therapeutic application.
MATERIALS AND METHODS
Ethics Statement
Animal experiments were carried out in accordance with the
National Institute of Health Guide for the Care and Use
of Laboratory Animals. The study protocol was approved
by the Animal Subjects Review Board of the First Affiliated
Hospital of Shihezi University School of Medicine (permit
no. 2008LL11). Surgeries were carried out under sodium
pentobarbital anesthesia.
Generation of Recombinant hNeuritin
Protein
Pichia pastoris strain GS115 (Invitrogen) and the P. pastoris
expression vector pPIC9K (Invitrogen, Carlsbad, CA, USA)
were used to produce recombinant hNeuritin protein. The
hNeuritin fragment (without the glycosylphosphatidylinositol
anchor) was cloned into pPIC9K with a 6 × His tag at the
5′-end. The GS115/pPIC9K-His-Neuritin plasmid was stored at
−80◦C until use (Zhang et al., 2015). For protein expression,
cells harboring GS115/pPIC9K-His-Neuritin were thawed in
yeast extract peptone dextrose medium (220 rpm, 30◦C, 10–
16 h), then transferred to BMGYmedium [1%(v/v)] and cultured
under the same conditions until the optical density exceeded
2.0. The cell suspension was centrifuged (6000 rpm, 5min), and
the precipitates was collected and dissolved in BMMY medium
containing 1% methanol to induce His-Neuritin expression (220
rpm, 30◦C, 72 h); 100% methanol was added for 24 h to a
final concentration of 1%. Then the supernatant containing
His-Neuritin was collected by centrifugation (14,000 rpm, 4◦C,
30min), then mixed to 65% saturation with (NH4)2SO4 while
stirring (4 ◦C, 12 h). The following day, the protein sample was
collected by centrifugation (14,000 rpm, 4◦C, 30min) and the
precipitate was dissolved in the chromatography solution, which
was applied to a HisTrap FF Crude pre-packed column (GE
Healthcare Life Sciences, Little Chalfont, UK). Eluted protein
samples were dialyzed to reduce the salt concentration and
concentrated using Amicon Ultra-15 filter units (Millipore,
Billerica, MA, USA). Protein concentrations were determined by
the Bradford method (Bio-Rad Protein Assay; Bio-Rad, Hercules,
CA, USA), and expression was confirmed by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and
Western blot using amouse anti-His antibody (1:500, CW0257A;
cwbiotech, Shanghai, China). Protein purity was determined by
SDS-PAGE as the optical density of the Neuritin band divided
by that of total protein in the same lane. Protein solutions were
lyophilized at −56◦C in a freeze dryer for subsequent assays
(FD5510; SIM International, USA).
Treatment of PC12 Cells with Recombinant
hNeuritin
PC12 cells were cultured in Roswell Park Memorial Institute
1640 medium, 5% fetal bovine serum, and 10% horse serum
(Gibco, Grand Island, NY, USA) at 106/35mm dish as previously
described (Green, 1977). The PC12 cells were passaged and
seeded onto poly-L-lysine-coated dishes at a density of 105/35
mm dish. Known volumes of medium containing hosphate-
buffered saline (PBS; negative control), 6 × His protein (to
exclude the effect of His tag, 1µg/ml, Bioss, China), and the
purified recombinant hNeuritin protein (1µg/ml) were added;
the PBS control group was treated with an equal volume of His
protein. Morphological changes in the cells were observed 3 days
after treatment under an inverted phase-contrast microscope
(Olympus, Tokyo, Japan), and five random fields were imaged
per dish; samples for each groupwere prepared in 3 replicates and
the experiment was repeated three times. Neurites were analyzed
using ImageJ software (National Institutes of Health, Bethesda,
MD, USA). To exclude variability in the number of cells per field,
neurites were quantified as neurite length/cell.
Animals
Wistar rats of both sexes (n= 80; 12-week-old) weighing 200 g to
220 g were obtained from the Institute of Epidemiology, Xinjiang
Uygur Autonomous Region under standardized laboratory
conditions in an air-conditioned room at constant temperature
(23◦C ± 2◦C) on a 12:12-h light/dark cycle with free access to
food and water. The animals were randomly assigned to one
of the following four groups (n = 20 each): sham operation,
normal saline (NS) group, 3-µg Neuritin (N3), and 5-µg
Neuritin (N5). Five rats were selected for testing at each time
point.
Sciatic Nerve Injury Model
Rats were fixed in a prone position and anesthetized by
intraperitoneal injection of 0.5% sodium pentobarbital (40mg/kg
body weight, Sigma-Aldrich, St. Louis, CA, USA). A 3-cm
longitudinal incision was made under sterile conditions in
the posterolateral area of the left buttock and the left sciatic
nerve was fully exposed by blunt dissection. In the sham
group, surgery stopped at the fascia before the skin was closed.
The remaining groups were subjected to severe clamp injury
by application of pressure onto sciatic nerve with gearless
mosquito forceps (one ratchet of the forceps) at a point 0.5
cm below the piriformis for 30 s. A damaged section 5mm
long was observed after clamping in which the nerve fibers
were ruptured but the epineurium was left intact. The nerve
tissue became thin at the lesion site, which was defined as
neurotmesis according to the Seddon classification. We marked
the epineuriums with 9–0 microsutures, reset the nerves, applied
gelatin sponges (0.5 × 0.5 × 0.5 cm) infiltrated with NS or
different concentrations of Neuritin to the site of injury, and
separately sutured the fascia and skin (Smith et al., 1993). After
the operation the rats showed immediate behavioral signs of
nerve injury; that is, the ipsilateral leg and foot muscles were
completely paralyzed; the claw reflex disappeared; and the lower
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extremities showed claudication, with toes that were completely
closed.
Neuritin Treatment
The groups were treated as follows: sham rats underwent sham
operation only; rats in the NS group were subjected to sciatic
nerve injury and gelatin sponges that were infiltrated with 1
ml NS; and rats in the N3 and N5 groups were subjected to
sciatic nerve injury and gelatin sponges that were infiltrated with
Neuritin at 1.5 and 2.5µg/100 g body weight, respectively, in 1ml
NS (for doses of 3 and 5µg, respectively). These doses of Neuritin
did not cause cytotoxity (Li et al., 2008). All animals except those
in the sham groups received daily intramuscular injections of
Neuritin at the injury site for 1 week after the operation at the
indicated doses. The frequency of injection was then changed to
every other day for 3 weeks and then to every 3 days for 2 weeks.
Assessment of Sciatic Nerve Function
Walking tests were performed 2, 4, 6, and 8 weeks after sciatic
nerve injury to determine the sciatic nerve function index (SFI).
After dipping the hind feet in carbon ink, each rat was placed at
one end of a paper-lined walkway; four or five footprints were left
on the paper when rat walked to the other end. Sufficiently clear
footprints from experimental (prefix E) and normal (prefix N)
limbs were evaluated according to three parameters: foot print
length (PL; distance from the heel to the third toe); toe spread
(TS; distance from the first to fifth toe); intermediary toe spread
(IT; distance from the second to the fourth toe). The Bain–
Mackinnon–Hunter SFI was then calculated using the formula
(Hare et al., 1992):
SFI = −38.3 [(EPL−NPL)/NPL]+ 109.5 [(ETS−NTS)/NTS]
+13.3 [(EIT−NIT)/NIT]− 8.8
The test was repeated three times and the average of three
readings was analyzed. SFI values ranged from −100 to 0, with
0 indicating normal or complete recovery of nerve function and
−100 indicating total loss of function (Bain et al., 1989).
Electrophysiology
Electrophysiological recordings were carried out 2, 4, 6, and
8 weeks after sciatic nerve injury. After the walking tests,
five rats in each group were anesthetized by intraperitoneal
injection of 3% sodium amobarbital (40mg/kg body weight,
Sigma-Aldrich). A longitudinal incision was made under sterile
conditions in the posterolateral part of both legs; the skin
and muscles were separated layer by layer to fully expose the
sciatic nerve, which were kept wet during recording that were
carried out at room temperature (∼25◦C) using a BL-420E
multifunctional biological signal recording system (Chengdu
TME Technology, Chengdu, China). Sciatic nerves from the
injured and contralateral uninjured sides were exposed and a
ground electrode was connected to metal clamps was attached to
the cut edge of the tissue. Stimulating and recording electrodes
FIGURE 1 | Structure and purification of recombinant hNeuritin. (A) Schematic illustration of hNeuritin protein structure. Neuritin is a small glycoprotein of 142
amino acids; the soluble form used in this study is generated via cleavage of the signal peptide. (B) Affinity chromatography elution profile of the hNeuritin. Peaks 1
represents effluent and peak 2 is the eluted protein. (C) SDS-PAGE analysis of recombinant hNeuritin. M, protein marker; lane 1, culture supernatant before methanol
induction; lane 2, culture supernatant after 3 days of methanol induction; lane 3, protein effluent; lane 4, eluted protein. (D) Western blot analysis of recombinant
hNeuritin. M, protein marker; lane 1, protein eluted with anti-His antibody (∼11 kDa).
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were hooked proximal and distal to the injury site, respectively,
with good contact with the nerve stem. Nerve conduction
velocity (NCV) was assessed by inducing a compound action
potential from the stimulating electrode at the proximal end
and recording from the recording electrode at the distal end of
the injury site. NCV was calculated as the impulse conduction
distance divided by conduction time. The degree of recovery of
NCV (experimental data/control data × 100%) was calculated
using the contralateral side as an internal control. Experimental
and control data were obtained from the lesion and contralateral
sides, respectively.
Evaluation of Gastrocnemius Muscular
Strength
At 2, 4, 6, and 8 weeks after the electrophysiological testing, the
gastrocnemius muscle in both legs were cut at the end of the
Achilles tendons, and the muscles (1 cm length) were separated
and connected to a strength transducer via a 1–0 silk suture. The
maximal tetanized contractile strength of each sciatic nerve was
recorded at a maximum stimulus intensity of 50 Hz and pulse
width of 2 ms for 3 s. The degree of recovery of gastrocnemius
muscular strength was calculated as (experimental data/control
data)× 100%.
Morphological Analysis
At 2, 4, 6 and 8 weeks after injury, five rats from each
group were sacrificed by cervical dislocation and the entire
sciatic nerve from both injured and uninjured sides were
collected and fixed in a 10% paraformaldehyde solution for
24 h. Segments 2mm in length were removed from an area
2 and 4mm distal to the lesion site. The tissues were
FIGURE 2 | Effects of Neuritin on PC12 cells. (A–C) Cell morphology in the
PBS control (A), 6 × His protein control (B), and recombinant hNeuritin (C)
after 3 days of incubation. (D) Quantification of neurite length (n = 3). **P <
0.01 vs. PBS group; ##P < 0.01 vs. 6 × His protein group. Scale bar =
50µm.
embedded in paraffin and 7-µm serial sections were cut for
hematoxylin and eosin (H&E) staining, Sevier-Munger silver
staining (AgNO3, Shenbo Chemical, Shanghai, China), and
myelin staining with Solechrome Cyanin R staining (Like
Trading, Guangzhou, China). Image-Pro Plus software (Media
Cybernetic, Rockville, MD, USA) was used to obtain average
counts of myelinated fibers (µm−2) in five randomly selected
fields per group.
Immunohistochemical Analysis
Paraffin-embedded sciatic nerve tissue specimens were cut at a
thickness of 5µm and the sections were examined for expression
of growth associated protein (GAP) 43 and neurofilament (NF)
200. Sections were rinsed three times with water and incubated
in 0.3% hydrogen peroxide for 10min, in 0.01M citric acid
for 10min, and goat serum for 20min. The sections were
then incubated overnight with monoclonal antibodies against
GAP43 (1:1200, ab50608) or NF200 (1:1000, ab24574) followed
by incubation with a goat anti-mouse IgG (Bio-Rad), and
then visualized by treatment with a biotin-avidin-peroxidase
FIGURE 3 | Functional recovery after sciatic nerve injury. (A)
Walking-track analysis of rats at weeks 2, 4, 6, and 8 after sciatic nerve injury.
(B) SFI showing the recovery of injured sciatic nerve at indicated time points
(n = 5). *P < 0.05, **P < 0.01 vs. NS group.
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complex using diaminobenzidine tetrahydrochloride as the
chromogen (Bio-Rad, China). Sections were counterstained with
hematoxylin for 2min.
Statistical Analysis
Results are expressed as mean ± standard deviation. Differences
between two groups (NS vs. N5, or NS vs. N3) and among
groups were evaluated with the least significant difference (LSD)
post-hoc test and analysis of variance, respectively. P < 0.05 was
considered statistically significant.
RESULTS
Identification of Recombinant hNeuritin
Protein
The structure of hNeuritin protein is shown in Figure 1A.
Soluble recombinant hNeuritin was collected by linear elution
FIGURE 4 | Functional recovery in the sciatic nerve at different time
points after injury, as determined by electrophysiological recordings.
(A) Recovery of gastrocnemius muscular strength at weeks 2, 4, 6, and 8 after
nerve injury. (B) Recovery of NCV at weeks 2, 4, 6, and 8 after nerve injury.
The degree of recovery of gastrocnemius muscular strength and NCV were
calculated as experimental data/control data × 100%. *P < 0.05, **P < 0.01
vs. NS group.
by monitoring the major protein absorption peaks when flows
through a HisTrap column packed with Ni Sepharose 6 Fast Flow
Crude (Figure 1B). SDS-PAGE analysis indicated that the protein
was highly expressed, with a purity >95% (Figure 1C). Western
blot analysis using an anti-His monoclonal antibody confirmed
the identity of the protein as recombinant hNeuritin, which had
a molecular weight of ∼11 kDa (Figure 1D), as confirmed by
Coomassie staining.
Neuritin Promotes Neurite Outgrowth in
PC12 Cells
PBS, 6× His protein, and purified Neuritin were added
to the medium of PC12 cells for 3 days. Cell morphology
was observed under an inverted phase contrast microscope.
Small, round PC12 cells lacking neurites were observed
in the PBS (Figure 2A) and 6 × His (Figure 2B) control
groups. In contrast, PC12 cells treated with recombinant
hNeuritin showed a network of neurites (Figure 2C),
demonstrating that the protein was biologically active (P
< 0.01). Increase in neurite formation in the presence of
Neuritin was confirmed by quantitative analysis of neurite
number (Figure 2D).
Neuritin Accelerates Functional Recovery
of Injured Sciatic Nerve
A walking-track test was carried out to determine the effects of
Neuritin on the recovery of sciatic nerve function (Figure 3A).
SFI was lower in all experimental groups as compared to the
sham group at each time points (P < 0.01), indicating limb
dysfunction following nerve injury (Figure 3B). Nerve function
began to recover at 4 weeks, with a significant difference
appearing between the N5 and NS groups (N5: −33.61 ±
2.24, NS: −43.59 ± 8.30; P < 0.05). Although N5 and N3
groups showed similar trends in recovery of SFI values, these
were similar between N3 (−39.98 ± 8.49) and NS groups.
At week 6, nerve function was higher in both Neuritin-
treated groups than in the NS group (N5: −25.16 ± 3.83, N3:
−24.80 ± 6.02, NS: −39.49 ± 6.53; P < 0.01). At week 8,
the SFI values were higher in all experimental groups, but a
significant difference was observed between the Neuritin and
NS groups (P < 0.01). These results indicate that Neuritin
treatment accelerates functional recovery of rat sciatic nerve after
injury.
Assessment of Gastrocnemius Muscular
Strength
Gastrocnemius muscular strength was reduced in all
experimental groups relative to the sham group from week
2 to week 6 (P < 0.01), consistent with loss of muscle innervation
(Figure 4A). However, muscular strength recovered by the
4-week time point, with a significant difference between the
N5 and NS groups (N5: 60.5 ± 3.2%; NS: 39.2 ± 4.3%, P <
0.05) but not between the N3 (33.3 ± 5.1%) and NS groups
(P > 0.05). At week 6, muscular strength had recovered
to a greater degree in both Neuriitn-treated rats relative
to the NS group (N5: 75.0 ± 3.2%, N3: 73.7 ± 3.2%, NS:
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45.5 ± 3.2%, P < 0.05). At week 8, muscular strength in
both Neuritin treatment groups was comparable to that of
sham animals. These results provided further evidence that
Neuritin treatment accelerates the recovery of injured sciatic
nerves.
The NCV Assessment
Nerve conduction velocity (NCV) was reduced in all
experimental groups relative to the sham group at all time
points after injury (P < 0.01), indicating that neural conduction
was diminished (Figure 4B). NCV values began to recover by 4
FIGURE 5 | Regeneration of sciatic nerve fibers after injury. (A,B) H&E staining of nerve fiber cross sections in NS (A) and N5 (B) groups. Scale bar = 200µm.
(C,D) Sevier-Munger staining in NS (A) and N5 (B) groups. Scale bar = 200µm. (E,F) Myelin (Solochrome Cyanine R) staining in NS (A) and N5 (B) groups; arrows
indicate newly formed myelin sheaths. Scale bar = 100µm. (G) Quantitative analysis of the number of myelinated axons in each group (n = 5). **P < 0.01 vs. NS
group. (H) Average counts of myelinated nerves in each group at weeks 2, 4, 6, and 8 after injury (n = 5). Myelinated fibers were counted at 3mm distal to the lesion
side and the corresponding area in the contralateral side. The average counts of myelinated fibers in each side were calculated as numbers of myelinated fibers/unit
area. And then, residual myelinated axon counts were calculated as experimental data/control data × 100%. *P < 0.05, **P < 0.01 vs. NS group.
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weeks, with significant differences observed between Neuritin
and NS groups (N5: 54.21 ± 0.2%, N3: 54.51 ± 4.23%, and NS:
14.74 ± 3.07%; P < 0.01). NCV values increased from week 6
to 8 to a greater degree in Neuritin-treated groups (P < 0.05);
for instance, at week 8, NCV in N5 reached 70% of the original
value, which was 2-fold higher than in the NS group (P < 0.01).
Effects of NRN1 Treatment on Nerve
Regeneration after Sciatic Nerve Injury
Nerve Fiber Regeneration
Hematoxylin and eosin (H&E) staining of sciatic nerve cross
sections showed that in the NS group, nerve fibers were loose and
curled, with obvious neurotmesis at 2 weeks after injury; there
was also negligible nerve regeneration at 4 weeks (Figure 5A). In
contrast, nerves had regenerated to a greater degree and showed
better organization in the N5 group (Figure 5B). AgNO3 staining
of nerve fibers showed varying degrees of disarray 2 weeks after
injury. At week 4, newly formed nerve fibers were visible in
Neuritin-treated animals as compared to those in the NS group,
especially the N5 group (Figures 5C,D). At week 6, nerve fibers
in the Neuritin groups were well ordered and thicker and more
dense than those in the NS group. There was no differences in
nerve morphology among groups at week 8.
Remyelination
Cross sections of sciatic nerves were stained with Solochrome
Cyanine R dye to visualize myelinated nerve fibers. The myelin
sheath was disorganized and poorly disordered in all animals 2
weeks after injury. From week 4 to 6, all experimental groups
developed myelin sheaths; in the N5 group, these were more
strongly stained and better organized than those in the NS group
(Figures 5E,F), as quantified in Figure 5G (P < 0.01). At week 8,
myelin sheaths were thicker in all experimental groups but this
change was most significant in the N5 group. The myelin sheath
was thin and sparse in the NS group, whereas in the N5 group it
was thicker and well organized. The average counts of myelinated
fibers were lower in all experimental groups relative to sham
animals from week 2 to 8 (P < 0.01; Figure 5H). However, by
week 4, the average counts of fibers was 2-fold higher in the N5
than in the NS group (N5: 55.5± 7.9% and NS: 28.4± 1.6%; P <
0.05).
Axonal Regeneration
To assess the effects of Neuritin on axonal growth, nerve
fiber sections were immunolabeled with antibody against the
axonal regeneration marker GAP43 4 weeks after injury. GAP43
expression was higher in the N5 group than in the NS group (P
< 0.05; Figures 6A–C). A similar trend was observed for another
axonal regeneration marker NF200 (P < 0.05; Figures 6D–F).
DISCUSSION
In this study we showed that recombinant hNeuritin restored the
structure and function of injured sciatic nerve fibers. We used
PC12 cells to evaluate the effect of Neuritin on cell morphology.
Given the short half-life of neurotrophic factors (Domanskyi
et al., 2015), we placed a Neuritin-filled gelatin sponge directly
on the site of injury to ensure sustained release, combined with
intramuscular injection of Neuritin for 4 weeks to maintain
a high circulating level of protein. To exclude inter-individual
variability, all indices were calculated by experimental/control
data (such as SFI calculation).
To determine whether Neuritin can promote recovery in
injured sciatic nerve, we evaluated changes in nerve and muscle
FIGURE 6 | Axonal regeneration following sciatic nerves injury. (A,B) GAP43 expression in NS (A) and N5 (B) groups 4 weeks after injury. Scale bar = 200µm.
(C) Quantification of OD ratio for GAP43 expression (n = 5). *P < 0.05 vs. NS group. (D,E) NF200 expression in NS (D) and N5 (E) groups 4 weeks after injury. Scale
bar = 200µm. (F) Quantification of the OD ratio for NF200 expression (n = 5). *P < 0.05 vs. NS group.
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function. The SFI was increased by Neuritin at 4 weeks after
injury, indicating functional improvement of lower limb muscles
and nerves. Gastrocnemius muscle strength and NCV were also
improved by Neuritin treatment, with the 5-µg dose having an
earlier and more potent effect.
Peripheral nerve function depends on nerve fiber organization
(Ivanovic et al., 2012; Gordon et al., 2014). The observed recovery
of NCV indicated the restoration of functional nerve fibers; their
regular arrangement was confirmed by H&E and silver staining.
Moreover, nascent nerve fibers were observed in the Neuritin-
treated group. NCV is generated throughmyelinated nerve fibers;
we found that Neuritin treatment restoredmyelination of injured
nerves, thereby accelerating the recovery of NCV.
Since nerve fibers are regenerated from surviving neurons
(Xu et al., 2010; Sherpa et al., 2014), we examined changes in
the expression of GAP43 and NF200, which are secreted from
neurons and act on axons (Liang et al., 2015; Fallini et al.,
2016). Neuritin treatment increased the levels of both proteins,
possibly by retrograde transport through the lesioned fiber to
the cell body where it induced gene expression. A previous
study demonstrated that Neuritin is antero- and retrogradely
transported along the sciatic nerve in vivo (Karamoysoyli et al.,
2008). GAP43 is required for growth cone extension and axon
guidance, and may induce the expansion of the presynaptic
membrane by promoting vesicle fusion or endocytosis at the
presynaptic terminal (Di Giovanni et al., 2005a). NF200 is
the main cytoskeletal component of axons and is required for
stabilization of axonal structure (Black, 2016). During nerve fiber
regeneration, GAP43 and NF200 may stimulate the sprouting of
axon collaterals and dendrites, thereby increasing the surface area
of nerve endings so that new synaptic contacts can be established
and contributing to the orderly arrangement of nerve fibers
through stabilization of the cytoskeleton.
In conclusion, our results demonstrate that a high
concentration of Neuritin in the microenvironment of the
injured sciatic nerves slows retrograde degeneration and
promotes regeneration. Moreover, we found that Neuritin
treatment accelerated the functional recovery of nerve fibers and
target tissue. These results highlight the therapeutic potential of
Neuritin for the repair of injured nerves.
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